Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

A NOVEL & TAILORABLE DRUG DELIVERY DEVICE FOR THE TREATMENT OF PERIODONTITIS

Award Number: R43DE018849
ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/13/2008
PERIOD OF PERFORMANCE END DATE: 12/31/2010

Group Awards By:

View Award Description

A NOVEL & TAILORABLE DRUG DELIVERY DEVICE FOR THE TREATMENT OF PERIODONTITIS - DESCRIPTION (provided by applicant): This application is directed toward the development of a therapeutic drug conjugates with the intention of providing a cost effective adjunct to scaling and root planing procedures for the reduction of pocket depth in patients with adult periodontitis. This proposed study falls under an existing program announcement (PA-06-085) focusing on the "development of novel delivery systems for rapid and/or sustained, on-demand release of therapeutic agents (e.g., antimicrobial, anti-inflammatory, antibodies, peptides, nucleotides, small molecule receptor agonists/antagonists) in the oral cavity". To this end, the objective of this application will be to formulate and test the ability of several novel derivatives of an existing therapeutic agent that has proven to be effective against neutrophil-derived proteases in early testing, against several known periodontal pathogens and proteases. The major Specific Aims of this work are: 1) to test the effectiveness of the formulations to inhibit facultative anaerobes associated with periodontal disease and 2) to test their effectiveness in inhibiting the activities of bacterial and host-derived proteases that are believed to play major roles in this disease. This innovative and rational design resulted from the idea that addressing multiple biomolecular targets within the periodontal pocket environment should result in a more favorable environment for healing. Thus, the development of a biodegradable, cost-effective microsphere-based treatment for periodontitis that modulates an array of proteases and addresses bacterial burden is the subject of a clinical investigation. Public Health Significance: Periodontal disease is the most common chronic infectious disease in the world. In the U.S., a country known for good oral healthcare, more than 50 percent of adults have gingivitis and 35 percent have periodontitis. Dental disease has both a significant social and economic impact in the U.S. and is estimated to cause 189 million missed hours of work each year and expenses attributed to the disease of more than $60 billion. When the growing evidence that tooth and periodontal disease contributes to other costly systemic diseases such as cardiovascular, pulmonary, digestive and liver diseases, and preterm births, and diabetes are considered, the costs are significantly higher.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2010 ( Subtotal = $0 )
2010	2008	IASIS MOLECULAR SCIENCES LLC	3305 EAST MORAN VISTA LANE	SPOKANE	WA	99223	SPOKANE	USA	Oral Diseases and Disorders Research	001	1	7/14/2010	NEW	$0
2010	2008	IASIS MOLECULAR SCIENCES LLC	3305 EAST MORAN VISTA LANE	SPOKANE	WA	99223	SPOKANE	USA	Oral Diseases and Disorders Research	000	1	2/4/2010	NEW	$0
														Subtotal = $0

Issue Date FY: 2009 ( Subtotal = $0 )
2009	2008	IASIS MOLECULAR SCIENCES LLC	3305 EAST MORAN VISTA LANE	SPOKANE	WA	99223	SPOKANE	USA	Oral Diseases and Disorders Research	000	1	3/13/2009	NEW	$0
														Subtotal = $0

Issue Date FY: 2008 ( Subtotal = $158,496 )
2008	2008	IASIS MOLECULAR SCIENCES LLC	3305 EAST MORAN VISTA LANE	SPOKANE	WA	99223	SPOKANE	USA	Oral Diseases and Disorders Research	000	1	8/13/2008	NEW	$158,496
														Subtotal = $158,496

Grand Total All Awards = $158,496

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A NOVEL & TAILORABLE DRUG DELIVERY DEVICE FOR THE TREATMENT OF PERIODONTITIS

Award Number: R43DE018849

ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/13/2008

PERIOD OF PERFORMANCE END DATE: 12/31/2010

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer